Devyser secures a four-year tender in France for Devyser Compact
Devyser, a leading provider of advanced genetic testing solutions, has been awarded a new tender in...
News | September 15, 2019
Cancer is overtaking heart disease as the leading cause of death, according to a study published recently in The Lancet medical journal.
While heart disease remains the overall leading cause globally, the study of nearly 156k participants, across 21 countries over 11 years, has identified a trend that as living conditions improve, cancer begins to overtake heart disease. In middle-income countries cancer approaches the same rate, while in high-income countries it represents more than double the deaths of heart disease. These two diseases alone account for nearly 80% of deaths in middle-aged adults.
Devyser, a leading provider of advanced genetic testing solutions, has been awarded a new tender in...
Read More
Devyser is proud to announce that One Lambda Devyser Chimerism and Advyser Chimerism have been...
Read More
Devyser today announced that the Centers for Medicare & Medicaid Services (CMS) has issued its...
Read More
Devyser today announced the enrollment of the first patient in its Devyser Accept cfDNA clinical...
Read More